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An increasing number of examples of translational regulation at the level of termination has been recently reported in 
eukaryotes. This paper reviews our present knowledge on this topic and proposes an understanding of these regulations 
by relating the study of viral gene expression to a comprehensive i w of the mechanisms and components of the transla- 
tional process. 
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1. INTRODUCTION 
Termination is the last step of mRNA transla- 
tion and has never been as extensively studied as 
the initiation or elongation steps. However, ter- 
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mination has revealed itself to be the scene of 
unexpected events. A termination codon can play 
different characters in different scenarios: it can 
meet its usual partner, the release factor, and thus 
promote proper release of the terminated peptide 
chain, but it can also be recognized by an 'unfair '  
tRNA which will turn it into a sense codon, or it 
can even simply be ignored by a ribosome which 
either shifts reading frame before reaching it or 
slides past it. These various scenarios are just as 
many means of regulating ene expression in pro- 
karyotes as well as in eukaryotes. A general view of 
the control of termination in eukaryotes is 
presented here: the concept of termination is de- 
fined first, then the different scenarios are de- 
scribed in some detail and, finally, an attempt is 
made to understand regulation itself, i.e. its 
significance and the factors that modulate the effi- 
ciency of termination. 
2. THE CONCEPT OF TERMINAT ION 
The termination step can be defined as the active 
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process involved on the ribosome for the release of 
a polypeptide chain from the tRNA carrying the 
last amino acid incorporated in this polypeptide, a 
process that occurs when the ribosome encounters 
one of the so-called termination or nonsense 
codons. The denomination ‘termination’ codon 
suggests that such codons specify the end of the 
elongation of the polypeptide chain; the 
denomination ‘nonsense’ codon suggests that these 
codons cannot be recognized by any tRNA. The 
so-called termination or nonsense codons are the 
three codons UAA (ochre), UAG (amber) and 
UGA (opal) that are found at the end of coding 
regions on mRNAs. However, this classical defini- 
tion was jeopardized by the discovery that UGA 
specifies Trp in mitochondria [l] and by the ex- 
istence of variations from the standard genetic 
code in many organisms. 
Setting aside the variations concerning the 
meanings of several sense codons encountered in 
the mitochondrial DNA from many animal cells, 
yeast and filamentous fungi [2], it is noteworthy 
that a different version of the ‘universal’ genetic 
code is observed in the nucleus of some lower 
eukaryotes such as the ciliates. Tetrahymena ther- 
mophila, Stylonichia lemnae and Paramecium 
primaurelia or tetraurefia, all use UGA as sole ter- 
mination codon. UAA interrupts the ORF of the 
histone H3 [3] and cu-tubulin [4] genes in T. ther- 
mophila and S. lemnae respectively, whereas both 
UAA and UAG interrupt the ORF of the variable 
surface antigen [5,6] in the Paramecia; in all cases 
UAA and UAG encode Gln codons. A Gln-tRNA 
and its gene have been isolated from T. ther- 
mophila with an anticodon sequence complemen- 
tary to the UAA codon [7]. This Gln-tRNA”,ua 
recognizes in vitro both the UAA and the UAG 
codons [8]. Although a Gln-tRNA with a 
5 ’ -CUA-3 ’ anticodon, complementary to the 
UAG codon has also been found [8], none of the 
available gene sequences to date show internal 
UAG codons in T. thermophila. In addition to 
UAA and possibly UAG, the standard CAA and 
CAG codons are used to specify Gln but they are 
decoded by a Gin-tRNAu,uo [8]. 
The finding that different versions of the code 
are encountered in the nucleus of ciliates and in the 
mitochondria of various other eukaryotic 
organisms affects the concept of the ‘universality’ 
of the genetic code and makes it necessary to relate 
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the mechanism of termination to a given organism. 
All the cases of regulation that are discussed 
here are taken from organisms that use the three 
standard UAA, UAG and UGA termination 
codons. In addition it should be stressed that only 
natural situations and no mutant systems are con- 
sidered. 
3. THE SCENARIOS 
3.1. ‘Bona fide’ termination 
The sequence of events at peptide chain termina- 
tion in eukaryotes (reviews [9,10]) is still sketchy. 
When a ribosome reaches a termination codon, a 
peptidyl-tRNA sits at the ‘P site’, and the ‘A site’ 
is free. The unique eukaryotic RF initially isolated 
from rabbit reticulocytes clearly recognizes any of 
the three termination codons, and binds together 
with GTP to the ribosome. Hydrolysis of the 
peptidyl-tRNA ensues, catalyzed by the ribosomal 
peptidyltransferase. The release of the completed 
peptide chain is followed by GTP hydrolysis that 
promotes liberation of the RF from the ribosome, 
release of the deacylated tRNA and finally 
dissociation of the ribosome from the mRNA. 
Insights into the molecular mechanism of pep- 
tide chain termination should come from cloning 
and further characterization of the eukaryotic RF 
from different organisms. Comparing the se- 
quence of the mammalian RF with the prokaryotic 
and ciliate counterparts would help in pinpointing 
regions of the RF involved in recognition of the 
termination codons and in GTP binding. Indeed, 
prokaryotes use three different RFs for recognition 
of UAA and UAG, UAA and UGA, and GTP 
respectively (in addition to GTP recognition, RF3 
stimulates binding of RF1 and RF2 to the 
ribosome-termination codon complex). Thus, it 
could be speculated that domains related to these 
three different activities should be found in the 
unique mammalian RF. On the other hand, the 
putative ciliate RF, which should only recognize 
the UGA codon, would have a single UGA 
recognition domain in addition to a GTP-binding 
domain. 
In addition, studies of the antinomic process, 
namely nonsense suppression (i.e. reading of a 
nonsense codon leading to suppression of the ter- 
mination process), are also a tool to investigate 
further the mechanism of termination. Since 
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nonsense suppressor tRNAs can outcompete RF 
[ 1 l] for their common target, parameters that in- 
fluence the activity of the former should be taken 
into consideration to understand the activity of the 
latter. In particular, the demonstration that certain 
codon contexts around the termination codon 
favour nonsense suppression (see section 4.2.1) 
suggests that other contexts can be favourable for 
termination [ 121. Finally, the recent finding that an 
Escherichia coli nonsense suppressor mutant is 
mutated in the 16 S ribosomal RNA [13] opens the 
door to new experiments aimed at defining the sites 
in the ribosome involved in the interaction with the 
RF. 
3.2. tRNA recognition of termination codons 
Among tRNAs that recognize termination 
codons, tRNAs isolated from non-mutagenized 
cells are referred to as ‘natural’ suppressor tRNAs 
as opposed to ‘genetic’ suppressor tRNAs, exten- 
sively studied in prokaryotes and yeast [14,15]. 
Two types of natural suppressor tRNAs should be 
distinguished [ 161. First, normal major 
cytoplasmic tRNAs that misread termination 
codons: these tRNAs are involved in suppression 
of nonsense codons in eukaryotic viral mRNAs, 
thereby acting as essential mediators of regulation 
of gene expression at the translational level [17]. 
Second, minor aminoacyl-tRNA species harbour- 
ing an anticodon complementary to a termination 
codon: these tRNAs are possibly involved in the in- 
sertion of modified amino acids into proteins in 
response to specific termination codon sites. 
3.2.1. Nonsense suppression via misreading 
The first group of natural suppressor tRNAs has 
been investigated in a study of gene expression in 
tobacco mosaic virus (TMV), a plant virus with an 
RNA genome of ‘ + ’ polarity. Translation of the 
genomic RNA of this virus gives rise to two 
overlapping proteins initiated at the same AUG 
codon but differing in their C-terminal region. It 
was first demonstrated in vitro that the longer 
183 kDa protein results from the readthrough of a 
leaky UAG termination codon located at the end 
of the gene of the shorter I26 kDa protein [18]. 
This was later confirmed by determining the 
nucleotide sequence of the viral RNA genome [19]. 
The observation that both proteins are also pro- 
duced in vivo in tobacco protoplasts [20] led to the 
search for the tRNA species responsible for this 
natural suppression. Two closely related Tyr- 
tRNAs, with a 5’-GlkA-3’ anticodon, that 
specifically stimulate the readthrough of the TMV 
UAG codon in vitro, were isolated from 
uninfected tobacco leaves [21]. A Tyr-tRNA 
isolated from Drosophila melanogaster, also bear- 
ing a 5 ‘-G!PA-3 ’ anticodon, had already been 
shown to act as natural UAG suppressor during in 
vitro translation of TMV RNA [22]. Interestingly, 
the Tyr isoacceptor isolated from either system and 
bearing a 5 ’ -Q!PA-3 ’ anticodon (Q is a hyper- 
modified G base) is inactive in amber suppression. 
This observation suggests that the presence of the 
Q modification in the wobble position of the an- 
ticodon restricts recognition of the tRNA to the 
cognate UAC and UAU Tyr codons whereas the 
presence of an unmodified G permits the addi- 
tional recognition of UAG. A correlation between 
suppression activity and undermodification in the 
wobble position was also observed in wheat germ 
[23] and lupin tRNAs [24]. 
Misreading of a UAG nonsense codon by a Tyr 
5 ‘-GlkA-3 ’ anticodon implies an unconventional 
G:G interaction at the first position of the an- 
ticodon. It has been proposed [23] that the G of the 
anticodon could adopt a ‘syn’ conformation that 
would allow it to hydrogen bond with the G of the 
codon. On the contrary, the presence of a bulky 
side chain which projects out of the Q!PA an- 
ticodon loop [25], would prevent by steric hin- 
drance the Q nucleoside from adopting such a 
conformation. From a structural point of view this 
model would support the molecular basis for sup- 
pression of the TMV amber codon. However, re- 
cent crystal structure analyses of synthetic 
oligomers show that non-Watson-Crick pairings 
occur in B-DNA and that they do not involve the 
unusual ‘syn-anti’ but rather an ‘anti-anti’ base 
conformation [26,27]. Thus minor base conforma- 
tions do not always need to be invoked to explain 
unusual base-pair interactions (see also section 
4.2.2). 
A search for natural suppressor tRNAs active in 
TMV suppression has also been made in mam- 
malian systems. Surprisingly, neither of the two 
major Tyr isoacceptor tRNAs isolated from calf 
liver displays UAG suppressor activity: both 
possess a Q nucleoside in the anticodon, thus con- 
firming again the role of the level of base modifica- 
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tion on the codon reading pattern of tRNAs 
(review [28]). Yet, amber suppressor tRNAs have 
been purified from calf liver: they are Leu-tRNAs 
harbouring a 5 ’ -CAA-3 ’ and a 5 ’ -CAG-3 ’ an- 
ticodon, respectively. Mispairing (with regard to 
conventional rules) occurs at the second position 
of the anticodon in both species and also at the 
third position in the latter species [29]. Further 
discussion on the molecular mechanisms of non- 
cognate codon recognition can be found in a recent 
review [30]. 
A novel natural UAG suppressor tRNA has 
recently been isolated from mouse cells; it is a Gln- 
tRNA with a 5’-UmUG-3’ anticodon. Here, 
recognition involves mispairing in the third posi- 
tion of the anticodon. This tRNA which exists as 
a minor species in normal mouse cells, is markedly 
increased in MO-MuLV infected cells [3 11. This 
observation supports the hypothesis that Gln- 
tRNAumuo is actually involved in the readthrough 
occurring during MO-MuLV gene expression in 
vivo: indeed it was shown by protein analysis that 
a Gln residue is inserted in response to the UAG 
codon located at the end of the gag gene [32]. 
The ability of the natural suppressor tRNAs 
described above to recognize termination codons 
and the very likely involvement of some of them in 
regulation of viral gene expression are based on in 
vitro experiments. A clear-cut demonstration that 
unusual codon-anticodon pairing can also occur in 
vivo comes from recent results obtained in yeast by 
transformation of mutant strains with a multicopy 
plasmid carrying a normal tRNA gene. Over- 
expression of a Gln-tRNA with a 5’-UUG-3’ an- 
ticodon or of a Gln-tRNA with a 5 ‘-CUG-3 ’ an- 
ticodon (the anticodon sequences being deduced 
from the corresponding tRNA genes) can partially 
complement ochre or amber mutations, respective- 
ly [33,34]. In both cases in vivo suppression in- 
volves a G: U mispairing in the third position of 
the anticodon, as it does in the case of the mouse 
Gln-tRNAo,uo. It should be recalled that in 
ciliates Gln-tRNAu,oo is incapable of reading 
either UAG or UAA codons (see above). In con- 
clusion, the nature of the suppressor tRNA may 
vary with the system studied. This indicates that 
different anticodons may combine with a termina- 
tion codon, provided that the unorthodox interac- 
tion is properly stabilized, for example by the 
pattern of modified bases in the whole structure of 
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the suppressor tRNA. The effect of the overall 
primary sequence and conformation of the tRNA 
on the stabilization of codon-anticodon interaction 
may be so strong that, as in the case of the 
5 ’ -UmUG-3 ’ anticodon, an anticodon deprived of 
suppressor activity in a given tRNA (Gln- 
tRNAu,,,uo of ciliates) could acquire it when in- 
cluded in another tRNA body (Gln-tRNA”,uo of 
mouse). 
3.2.2. Nonsense suppression via specific 
recognition 
The tRNAs described above are able at times to 
misread nonsense codons, while maintaining their 
original specificity and function in protein elonga- 
tion (this latter point is demonstrated in the case of 
yeast [34] and is presumably also true in the other 
cases). Thus, they differ from authentic suppressor 
tRNAs that specifically read termination codons. 
Such nonsense suppressors, initially isolated from 
bovine liver, have now been discovered in human, 
avian and Xenopus laevis tissues (review [16]). 
They correspond to two minor Ser isoacceptors 
with anticodons 5 ’ -CmCA-3 ’ and 5 ’ -NCA-3 ’ (N 
is an unknown modification of U), the latter being 
complementary to the UGA termination codon. 
Both of them only read UGA codons, as 
demonstrated by ribosomal binding assays and by 
in vitro translation of ,fJ-globin mRNA. In addi- 
tion, these Ser-tRNAs can be phosphorylated in 
the presence of a specific kinase, yielding P-Ser- 
tRNA. These functional peculiarities may be cor- 
related to the unusual structural features of these 
tRNAs ([16] and references therein). Sequencing of 
the gene encoding the opal suppressor Ser- 
tRNANcA from human, rabbit, chicken and 
Xenopus has confirmed that the genome of higher 
eukaryotes encodes authentic suppressor tRNAs. 
The function of eukaryotic opal suppressors is 
still an open question. Direct involvement in pro- 
tein synthesis is dependent on the presence of a 
UGA codon interrupting an ‘open’ reading frame. 
Stewart and Sharp [35] have discussed in the 
following terms the possibility that the opal sup- 
pressor tRNA may serve to insert P-Ser into pro- 
teins; examining the codon usage for P-Ser 
residues in a P-Ser-rich protein such as casein (by 
comparison of the cDNA and protein sequences), 
they found that all P-Ser are inserted in response 
to standard Ser codons. However, of the four 
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AGU codons used to specify P-Ser in bovine LYS~ 
casein, two occur in the sequence AGUGA. 
Therefore, the authors suggest the interesting 
possibility that in these two cases the opal sup- 
pressor tRNAs would act as frameshifting tRNAs 
inserting P-Ser in response to an out-of-frame 
UGA codon overlapping a standard Ser codon 
[35]. This hypothesis would eliminate the uncom- 
fortable necessity of a UGA codon interrupting an 
open reading frame, but it assumes that a second 
frameshift event has to take place downstream of 
the P-Ser site of insertion in order to recover the, 
original reading frame. Two recent findings shed 
new light on potential roles of the opal suppressor 
tRNAs. Mammalian glutathione peroxidase 
[36,37] and E. coli formate dehydrogenase [38] 
both contain a UGA codon interrupting the ORF 
and encoding the Se-Cys found in the active site of 
both enzymes. Se-Cys is cotranslationally incor- 
porated into proteins [38,39] and it has been shown 
that the Se-Cys backbone in the glutathione perox- 
idase arises from Ser [40]. A Se-Cys-specific tRNA 
has been identified in rat liver [41] but its primary 
sequence remains to be determined to verify its 
identity with the opal suppressor tRNAs described 
above. Meanwhile, one could test whether or not 
the opal suppressor tRNAs are able to direct Se- 
Cys insertion at least into mouse glutathione 
peroxidase. In E. coli a gene whose product is in- 
volved in the incorporation of selenium into 
selenoproteins has just been sequenced [42]. This 
gene encodes a Ser-tRNA with an anticodon com- 
plementary to the UGA termination codon and 
bears unusual structural features. This finding 
defines the Se-Cys incorporation pathway: the 
UGA termination codon is recognized by a natural 
suppressor tRNA aminoacylated with Ser; a 
specific enzyme most likely modifies the Ser 
residue bound to the tRNA into Se-Cys which 
would then be incorporated into proteins. In con- 
clusion, the UGA codon generally specifies chain 
termination but it can also be recognized, within 
the same cell and in some mRNAs only, as en- 
coding Se-Cys. This raises the intriguing question 
of how the cell distinguishes between these two 
functions (see section 4). 
3.3. Frameshift 
Skipping a termination codon 
elongation when a ribosome 
may occur during 
shifts from one 
reading frame to another (+ 1 or - 1 frameshift) at 
a position in the mRNA upstream from that ter- 
mination codon. Several natural frameshifts have 
been described in prokaryotes and eukaryotes and 
recently reviewed ([43], table 2). In eukaryotes, 
frameshift is required for the expression of 
retroviruses and related systems [43] and for the 
expression of a coronavirus [44]. In some cases as 
discussed below, the frameshifted products have 
been characterized by protein sequencing and the 
site of frameshift localized. 
3.3.1. Retroviral systems 
All retroviruses express their pol gene by syn- 
thesizing a gag-pof polyprotein that is subsequently 
cleaved to mature components by a virus-encoded 
protease. On the basis of their genetic organization 
and with regards to the expression of the pal 
(reverse transcriptase) and the pro (protease) 
genes, four classes may be distinguished among 
retroviruses. They are depicted in fig. 1. 
Representatives of the first class are MO-MuLV 
and other murine leukemia and sarcoma viruses. 
The gag and pol genes are in the same reading 
frame and expression of the latter occurs via sup- 
pression of the gag gene termination codon. The 
region spanning the end of the gag gene and the 
beginning of thepol gene (encompassing the amber 
termination codon), encodes the viral protease 
responsible for cleavage of the gag polyprotein 
precursor into the mature core proteins [45]. The 
protease from MO-MuLV [32] has been sequenced 
establishing the suppression event and revealing 
the presence of a Gln inserted in response to the 
nonsense codon (see section 3.2). 
The prototype of the second class is RSV in 
which the pal ORF is - 1 with respect to that of 
gag. The N-terminus of the mature reverse 
transcriptase maps downstream of the gag amber 
termination codon, itself at the end of the overlap 
between the two ORFs. The protease cleaving the 
gag precursor is encoded by the gag ORF and lies 
at the C-terminus of the gag polyprotein [46]. 
Despite early statements envisioning a splicing 
event that would piece together on the same 
reading frame the gag and the pol genes with 
removal of the termination codon [46], RSV is one 
of the first examples of frameshift in eukaryotes. 
Strong evidence in favour of a frameshift comes 
from experiments using in vitro transcripts ob- 
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Fig. 1. Schematic representation of the relative arrangements of 
gag, pro and pol genes in retroviruses. Four classes are 
distinguished on the basis of the type of expression of the 
protease and the reverse transcriptase genes. Regions encoding 
gag, pro, ‘X’ and pal are indicated. All overlapping reading 
frames are - 1 compared to the upstream ORF. Coding regions 
are not drawn to scale, since ORF and overlaps vary in size 
among viruses of the same class; only the relative positions of 
each ORF are highlighted. The prototype virus of each class is 
indicated. o = suppressible termination codon. 
tained from cloned RSV cDNA [47]. These 
transcripts begin upstream of the gag initiation site 
and terminate within the pal reading frame far 
downstream from the gag termination codon. 
Upon in vitro translation in a reticulocyte lysate, 
the gag-pol RNA transcript produces the expected 
gag polyprotein and a larger polypeptide that can 
be immunoprecipitated with anti-reverse transcrip- 
tase and anti-gag serum. The size of the larger 
polypeptide is in agreement with that of a gag-pol 
fusion protein synthesized from the cloned RSV 
fragment indicating that these sequences can pro- 
mote frameshift in vitro. 
To the third class belong viruses such as the 
AIDS virus: HIV-l [48-501 and Visna virus [51] in 
which the protease is encoded by the 5’-end of the 
pal ORF which is out of frame with the gag ORF. 
Therefore, it is likely that as in RSV, a single 
frameshift event is required for the synthesis of the 
gag-pal precursor. Indeed, it has been very recently 
demonstrated that a - 1 frameshift occurs in 
HIV-l gag-pal expression by in vitro translation of 
constructs carrying the presumptive frameshifting 
region. The amino acid sequence of the fusion pro- 
tein derived from these constructs has made it 
possible to localize the site of frameshift ([52] and 
see section 4.2.1.). 
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Finally, in the fourth class fall viruses in which 
separate reading frames are used for the synthesis 
of gag, pro and pal. For example, sequence 
analysis of the MMTV genome [53,54] has reveal- 
ed three overlapping ORFs in the 5 ‘-part of the 
genome. The presence in the derived amino acid se- 
quence of protease and reverse transcriptase do- 
mains common to other retroviruses suggests 
assignment of each ORF to gag, X-pro (‘X’ is a 
protein domain of unknown function) and pal, 
respectively. Three nested gag-related polyproteins 
can be detected in vitro and in vivo that are consis- 
tent in size with the stepwise extended translation 
of the gag ORF. Similar experiments to those 
designed for RSV, i.e. transcription and transla- 
tion of variously truncated cDNA fragments en- 
compassing one or two overlaps, produce the 
expected gag-X-pro or gag-X-pro-p01 fused 
polyproteins. Clearly, the presumed single and 
double - 1 frameshifts have taken place in vitro 
[54]. More recently, complete amino acid sequenc- 
ing of a minor p30 protein found in MMTV virions 
has shown that this protein is encoded by the gag- 
X-pro overlap. Alignment of the amino acid se- 
quence of this viral protein with the nucleotide se- 
quence of the MMTV genome, provides a 
paramount demonstration of the frameshift event 
in vivo and highlights the site of frameshift [55]. It 
is interesting to note that in this class of viruses the 
region where frameshift occurs corresponds to a 
protein domain (~30 = ‘X’) different from that of 
the protease. 
A similar genetic organization to MMTV is 
shared by BLV [56,57] where the protease has been 
sequenced and shown to be fully encoded by the X- 
pro ORF [58]. Direct amino acid analysis of the 
gag-X-pro fusion protein at the junction between 
the two reading frames should definitely prove the 
occurrence of frameshifting. Analyses of their 
genome sequence suggest hat HTLV I [59] and II 
[60] and MPMV, a type D retrovirus [61] also 
belong to this fourth class of retroviruses. 
Accumulation of sequences might lead to the 
creation of more than four classes based on the 
strategies for pro and pal gene expression. Defin- 
ing a class requires, in addition to the nucleotide 
sequence, the complete amino acid sequence of the 
protein bridging two out of frame ORFs. In this 
regard, the case of FeLV is instructive. The 
nucleotide sequence of one strain (subgroup B) 
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suggests a strategy of expression of the third class 
[62] whereas the partial sequence of the protease of 
another strain (strain AB) seems to indicate a first 
class type of gene expression [63]. This discrepancy 
may of course rely on the fact that the sequenced 
cDNA clone of FeLV (subgroup B) could corres- 
pond to a defective RNA [63]. However, if one 
assumes that the nucleotide sequence of strain AB 
is identical to that of subgroup B, one should en- 
visage the combination of a readthrough and a 
frameshift event to account for FeLV protease syn- 
thesis, and thus the creation of a fifth class of gene 
expression among retroviruses. 
3.3.2. Retroviral-related systems 
Eukaryotic transposons show structural and 
functional similarities to retroviral proviruses [64]. 
Recently, it has been shown that yeast Ty 
transposons (Ty 1-15, Ty 1-17 and Ty 912) also 
share with retroviruses a common mechanism of 
gene expression: frameshift appears to be required 
for the expression of the tyb ORF through the syn- 
thesis of a tya-tyb fusion protein [65-671. The tyb 
ORF overlaps the tya ORF by 38 nt in a + 1 
reading frame. Protein tya exhibits structural 
features characteristic of a DNA-binding protein 
and protein tyb presents homologies to several 
reverse transcriptases. Careful Si mapping 
analyses, able to detect splicing of fragments as 
short as 5 bp, have definitely excluded the 
possibility that RNA processing is responsible for 
the synthesis of the tya-tyb fusion protein. On the 
contrary, tya-tyb-cxz interferon [65,67] or tya-tyb- 
lac z [65] fusion proteins are expressed exclusively 
when the reporter genes are in frame with the tyb 
ORF, leaving frameshift as the only possible 
mechanism of expression. Deletion studies have 
brought down to 31 nt the region of overlap in 
which frameshifting occurs, and within these 3 1 nt 
there is an 11 nt block that is completely conserved 
between different classes of transposons [67]. The 
translational strategy used in transposons for the 
tya-tyb fusion protein is remarkably similar to that 
of the retroviral gag-pal polyprotein. Since the tya- 
tyb fusion protein synthesized in vivo is accom- 
panied by a shorter product, presumably a 
cleavage product [65,66], it is reasonable to 
hypothesize that the tya-tyb moiety also encodes a 
protease as in retroviruses. 
On the basis of sequence homology with 
retroviral polymerases, other candidates for gene 
expression via frameshifting are the 17.6 cop&-like 
transposable element of D. mefanogaster 1681, 
hepadnaviruses and CaMV where the ORF en- 
coding the putative reverse transcriptase overlaps 
the ORF encoding antigen or coat proteins, respec- 
tively (review [69]). This genetic organization is 
once again reminiscent of the gag-pof ORFs of 
retroviruses. However, attempts to detect a CaMV 
fusion protein resulting from the suspected 
frameshift have so far failed. Recent observations 
indicate that an insertion in the CaMV genome 
that destroys the overlap between the coat protein 
and polymerase genes is viable; this suggests that 
the fusion of the translation products of these two 
genes is not obligatory [70]. 
Another non-retroviral-like case should be men- 
tioned: the - 1 frameshift occurring in a cor- 
onavirus, IBV, for the synthesis of the Fl-F2 
fusion protein, presumably encoding the putative 
viral polymerase [44]. 
3.3.3. Efficiency and possible mechanisms of 
frameshift 
In retroviral systems frameshift occurs with 
relatively high efficiencies ranging from 5 to 30%. 
For example, the gag-pol fusion protein in RSV is 
synthesized at 5% efficiency in vitro and in in- 
fected cells. The gag-X-pro and X-pro-pol fusion 
proteins of MMTV are synthesized in vitro at 23 
and 8% efficiency respectively, and these figures 
are consistent with the levels observed in vivo. 
Frameshift efficiency in vitro is 11% in the case of 
HIV-l and it is estimated to be as high as 25-30% 
for the Fl-F2 fusion protein of IBV. 
Although the site of frameshifting has been 
localized in at least two cases [52,55] the exact 
mechanism of frameshifting is still unclear. In 
principle, frameshifting could involve decoding of 
a triplet in another reading frame (implying skipp- 
ing of one or two but not three nt), non-triplet 
decoding, non-triplet translocation or some other 
translational quirk [43,71,72]. The data reported 
above are in favour of another model: a ‘slippage 
model’ [52,55]. The frameshifting tRNA would in- 
itially bind to its cognate codon in a standard 
triplet interaction at the ribosomal A site. Before 
the peptide bond is formed, a - 1 slippage would 
bring the aminoacyl-tRNA to mispair with the 
triplet in the - 1 reading frame, generating the 
7 
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frameshift. Such a model is based on the assump- 
tion that the interaction between the peptidyl- 
tRNA and its cognate codon is in fact wobbly, so 
that the third base of the codon at the P site can 
be read twice, once by its cognate tRNA and once 
by the frameshifting tRNA. Features that may pro- 
mote this series of unusual events are discussed 
below (see section 4.2.1), at the level of both the 
primary and secondary structure of the mRNA. 
Contrary to the work on nonsense suppressor 
tRNAs, isolation of frameshifting tRNAs has not 
been conducted in eukaryotic systems. Hopefully, 
the recent availability of natural mRNAs requiring 
a frameshift event for gene expression will help in 
the detection of such frameshifting tRNA species. 
Finally, in addition to frameshifting, another 
mechanism of skipping termination codons should 
be mentioned, although it has so far only been 
demonstrated in prokaryotes: ribosomal hops of 
up to 6 nt have been shown to occur on overlap- 
ping or non-overlapping homologous codons sur- 
rounding a termination codon [73]. More 
intriguing is the fact that in gene 60 of the E. coli 
bacteriophage T4, a 50 nt long intracistronic 
region that contains 6 termination codons is ap- 
parently skipped upon translation of the cor- 
responding mRNA [74]. 
4. UNDERSTANDING REGULATION 
The scenarios described above, which all directly 
or indirectly involve a termination codon, are 
means of regulating gene expression at the transla- 
tional level. In the following section an under- 
standing of the meanings of such regulations is 
proposed and the parameters that influence these 
regulations and that are ultimately responsible for 
the modulation of the different happenings at the 
termination codons are discussed. 
4.1. The rationales of regulation 
Translating a termination codon as a sense 
codon or skipping it by frameshift results in the 
synthesis of elongated proteins. These transla- 
tional strategies appear to be designed for the syn- 
thesis, from one mRNA species and one single 
Table 1 
List of animal and plant viral mRNAs with a suppressible termination codon 
Virus Readthrough Nucleotide Termination Size of proteins Nature of Amino acid Ref. 
sequence codon proteins sequence 
In vitro In vivo 
Molony murine leukemia 
virus (MO-MuLV) 
Rauscher murine leukemia 
virus (Ra-MuLV) 
Sindbis virus 
Middleburg virus 
Tobacco mosaic virus 
(TMV) 
Carnation mottle virus 
(CarMV) 
Beet necrotic yellow vein 
virus (BNYVV) 
Turnip yellow mosaic virus 
(TYMV) 
Tobacco rattle virus (TRV) 
Lucerne transient streak 
virus (LTSV) 
Soil-borne wheat mosaic 
virus (SBWMV) 
UAG Pr76g”p/Pr 1 8oP”p~p”’ + + + s/ns 
s/ns 
ns/ns 
ns/ns 
+ 3245 
_ 75 
_ 76.71 
_ 76 
+ ND 
+ + 
ND + 
UAG 
UGA 
UGA 
Pr80p”p/Pr200E”g~p”’ 
p23O/p270 
p23O/p270 
+ 
+ 
+ 
UAG 126 kDa/183 kDa + + + ns/ns 
ns/ns 
s/ns 
ns/ns 
ns/ns 
ns/ns 
_ 18-23 
UAG p3O/p77/plOO 
21 kDa/75 kDa 
+ + + _ 78,79 
_ 80,81 
_ 82 
_ 83 
_ 84 
ND + UAG + 
ND + 
+ + 
UAG 
UGA 
206 kDa/221 kDa 
140 kDa/l70 kDa 
+ 
+ 
ND ND ND p78/plOO 
19.7 kDa/28 kDa/ 
90 kDa 
+ 
ND ND ND + 
s/ns/ns _ 85 
ND, not determined; ns, nonstructural protein; s, structural protein 
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initiation event, of two (or more) related proteins 
differing in their C-terminal region and thus 
capable of different functions. Moreover, the two 
or more proteins are produced in different 
amounts depending on the efficiency of suppres- 
sion or frameshift. These strategies are essentially 
encountered in animal and plant viruses. This is 
not surprising because, due to the relatively small 
size of their genome, viruses possess an extremely 
compact genetic organization. Indeed, expression 
of proteins via nonsense suppression and 
frameshift fulfills two requirements: maximum ex- 
ploitation of nucleotide sequence and regulation of 
protein synthesis. For example, a retrovirus needs 
both the gag and pol proteins, but whereas the 
former is required in large amounts, as the precur- 
sor of the structural core proteins, the latter is only 
required in catalytic amounts; thus, a regulated 
suppression or frameshift mechanism ensures the 
production of an adequate ratio between the two 
precursor proteins. Tables 1 and 2 list the cases of 
regulation through nonsense suppression and 
frameshifting discussed in this paper; the termina- 
tion codon involved and the nature of the proteins 
concerned are indicated as well as whether the 
nucleotide and amino acid sequences have been 
determined. 
As discussed above, another rationale of the 
regulated recognition of termination codons is the 
possible insertion at specific sites in the polypep- 
tide chain of modified amino acids such as Se-Cys 
by natural opal suppressor tRNAs (see section 
3.2.2). It has recently been speculated, at a time 
when the exact nature of the Se-Cys inserting 
tRNA of E. coii was not known, that such an inser- 
tion could reflect an adaptation to changes in 
cellular physiology [87]. 
4.2. The determinants of regulation 
The question to be addressed now is how 
‘natural errors’ such as nonsense suppression and 
frameshifting can become regulatory devices. Two 
aspects have to be considered. On the one hand, 
the site of regulation: certain UAG codons are sup- 
pressible, others are not; certain UGA codons dic- 
tate the insertion of a modified amino acid, others 
do not; some codons are frameshift-prone, others 
are not. On the other hand, the efficiency of 
Table 2 
List of viruses and retroviral-related systems with frameshifting sites 
Sequence 
Nucleotide Amino acid 
Test 
in vitro 
Proteins 
concerned 
Frameshift 
type 
Ref. 
Rous sarcoma virus (RSV) 
AIDS virus (HIV) 
Visna virus 
Mouse mammary tumor virus (MMTV) 
Bovine leukemia virus (BLV) 
Human T-cell leukemia virus (HTLVI) 
Human T-cell leukemia virus (HTLVII) 
Mason Pfizer monkey virus (MPMV) 
Feline leukemia virus (FeLV) 
Ty transposon (l-15) 
Ty transposon (l-17) 
Ty transposon (912) 
17.6 copia-like element 
Avian infectious bronchitis virus (IBV) 
Hepadnaviruses 
Cauliflower mosaic virus (CaMV) 
Alfalfa mosaic virus (AIMV) 
+ _ 
+ + 
+ _ 
+ + 
+ _ 
+ + 
+ _ 
+ _ 
+ _ 
+ _ 
+ + 
+ gag-pro/p01 
+ gag/pro-p01 
_ gag/pro-p01 
+ gag/X-pro 
+ X-pro/p01 
_ gag/X-pro 
_ X-pro/p01 
_ gag/X-pro/p01 
_ gag/X-pro/p01 
_ gag/X-pro/p01 
_ gag/p01 
+ _ 
+ _ 
+ - 
+ _ 
+ - 
+ _ 
+ _ 
+ _ 
+ tya/tyb 
t tyahyb 
t tya/tyb 
_ ORFl/ORF2 
+ Fl/F2 
_ ‘gag’/‘pol’ 
_ ORFV/ORFVI 
+ 35 kDa/54 kDa 
-1 46,47 
-1 48-50,52 
-1 51 
-1 53-55 
-1 
-1 56-58 
-I 
-I 59 
-1 60 
-1 61 
a 62,63 
+1 65,67 
+1 67 
fl 66 
+1 68 
-1 44 
-1 69 
-1 69 
a 86 
a The mechanism remains to be clarified 
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regulation: which parameters modulate the level of 
frameshift or nonsense suppression to obtain the 
required amount of frameshift product. However, 
the aim here is not to discern among the factors 
those determining the specificity of regulation 
from those modulating the efficiency of regulation 
but rather to show that these two aspects are inter- 
related. 
4.2.1. Codon context: primary sequences and 
secondary structures 
To explain why some termination codons are 
suppressible and others not, and also to explain the 
variable efficiencies of suppression of different ter- 
mination codons, a major parameter that is 
generally invoked is ‘codon context’. This concept 
originated from studies on nonsense and missense 
suppression in prokaryotes (i.e. suppression of 
mutations leading to the appearance of a termina- 
tion codon in an ORF or to the replacement of a 
‘correct’ codon by an ‘incorrect’ one). It appears 
that translation of a given codon is influenced by 
the surrounding nucleotides. In particular, the 
presence of a purine 3’ of an amber codon 
stimulates nonsense suppression in vivo [88-901, 
suggesting that signals for termination of transla- 
tion could include sequences downstream of the 
nonsense codon. This hypothesis is supported by 
the analysis of the sequences urrounding natural 
termination codons. The compilation by Kohli and 
Grosjean [12] of the termination sequences of 
many eukaryotic and prokaryotic mRNAs reveals 
a significant bias in the usage of bases at the 
3 ‘-side of termination codons. All tight termina- 
tion codons in prokaryotes are followed by a U, 
and all leaky UGA codons are followed by an A 
[91]. Unfortunately, in eukaryotes no extensive 
comparison of the contexts of leaky with non- 
leaky termination codons that includes the cases of 
viral regulations examined to date has been made. 
One further observation may still give weight to 
the hypothesis of codon context in eukaryotes if 
not exactly to the conclusion drawn by the analysis 
of the mRNA sequences mentioned above. In three 
plant RNA viruses (TMV, BNYVV and TYMV) 
using natural suppression as a translational 
strategy, the UAG codon is flanked on either side 
by a CAA (Gln) codon [19,81,92]. This may be 
more than mere coincidence. 
If contexts favourable for suppression (and thus 
10 
unfavourable for termination) do exist, one may 
also envisage extra signals that could protect 
cellular termination codons from recognition by 
endogenous uppressor tRNAs. In this regard, the 
compilation of termination sequences in 
eukaryotic cellular mRNAs is deceiving: the fre- 
quency of two termination codons in tandem is 
very low, 60% of the mRNAs having a short ORF 
of more than 10 triplets downstream of their ter- 
minator [12]. However, it still remains that the in- 
jection of yeast genetic suppressor tRNAs into 
Xenopus oocytes has no dramatic consequences, 
leading only to a very limited number of changes 
(about 10%) in the two-dimensional pattern of the 
oocyte proteins [93]. Similarly, mammalian cell 
lines have been obtained that constitutively express 
low levels of genetically engineered suppressor 
tRNAs indicating that cell viability is not affected 
by the presence of tRNAs recognizing termination 
codons ([94] and references therein). These obser- 
vations all agree with the existence of protective 
codon contexts in cellular mRNAs, although the 
identity of such contexts remains undetermined. 
With the accumulation of viral and non-viral 
eukaryotic mRNA sequences, it may be possible to 
discern some pattern among translation termina- 
tion sequences from which a model for recognition 
of termination of protein synthesis by RF could 
emerge. A termination signal might be composed 
of two domains: a relatively constant region, the 
nonsense codon, and a variable region, the 
downstream sequence affecting efficiency of ter- 
mination [90]. To this speculation is probably 
related the fact that so far only amber and opal 
codons have been found to be naturally suppressi- 
ble. As suggested by Geller and Rich [95], termina- 
tion codons may well not be synonymous but the 
translational machinery may distinguish UAA as 
absolute termination signal from UAG and UGA 
as facultative termination codons. 
Codon context is not limited to the vicinity of a 
termination codon. Rather, it can be enlarged to 
more distant environmental sequences as observed 
in the case of frameshift. Inspection of the various 
shifty overlaps indicates that two types of se- 
quences, located upstream of the termination 
codon of the ORF of reference, can be found in the 
different systems where frameshift is operational 
[54]. The first conserved sequence is U.UUA block 
(where the triplet is located in the ORF of 
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reference) which is found at the gag/pof junction 
in RSV, at the gag/pro junction in HIV-l, at the 
X-pro/p01 junction of MMTV, BLV, HTLV I and 
II and at the Fl/F2 junction of IBV. Interestingly, 
the conserved U.UUA block is also found in the in- 
tergenic region of RNA3 of AlMV where 
frameshift has been hypothesized to explain the 
synthesis of an elongated viral translation product 
observed in vitro and in vivo [86]. The other con- 
served block, A.AAA.AAC, is found at the 
gag/X-pro overlaps of MMTV, BLV and HTLV I 
and II (see table 2 for references). These 
homopolymeric sequences may favour slippage of 
ribosomes: frameshifting might occur within such 
sequences or downstream. In the case of HIV-l it 
has been demonstrated that the site of frameshif- 
ting lies within the conserved U.UUA block. In 
MMTV the site is still debatable: it lies either at the 
end of the conserved A.AAA.AAC block or just 
beyond. The two conserved sequences eem to be 
so far specific for - 1 frameshift since they are not 
found in the tya-lyb overlap of Ty transposons. 
Other conserved sequences [67] might specify + 1 
frameshifts. 
Constructs containing the homopolymeric se- 
quences alone do not induce frameshift, as sug- 
gested by experiments in which the short putative 
frameshift window was inserted upstream of an 
out-of-frame reporter gene [44,52,54]. One cannot 
exclude the possibility that downstream sequences 
of the reporter gene exert a negative effect on 
frameshifting. A simpler explanation is that all the 
information required for frameshifting does not 
merely reside in the short conserved stretches of 
nucleotides but rather that additional sequences 
and/or structures bordering the overlap are also 
involved in promoting efficient frameshift. 
The search for a potential secondary structure of 
the mRNA in the vicinity of the frameshift site has 
been rewarding. Convincing stem and loop struc- 
tures can be drawn downstream of the gag/p01 
junction of HIV-l [52] and of the Fl/F2 junction 
of IBV [44]. They are also present downstream of 
the gag/X-pro junction of BLV, MMTV, HTLV I 
and II as well as downstream of the X-pro/pa/ 
junction of MMTV [54]. The size of the loops 
ranges from 18 nt (MMTV gag/X-pro) to 81 nt 
(MMTV X-pro/pot) and in all cases, except IBV, 
the termination codon of the first ORF lies 
upstream of the hairpin. These predicted secon- 
dary structures may provide important contribu- 
tions to an efficient frameshift by stalling 
ribosomes along the mRNA [41,51] and possibly 
masking the termination codon from the RF 
thereby increasing the chance for a frameshift 
event. 
4.2.2. A kinetic view of regulation 
The determinants of regulation of termination 
discussed so far are contained within nucleotide se- 
quence elements. This is not sufficient to give in- 
sights into the molecular interactions required for 
regulation. A comprehensive picture should con- 
sider protein synthesis as the outcome of com- 
peting interactions involving the aminoacyl-tRNA 
pool, the ribosomal binding sites and the transla- 
tional factors. Such a dynamic view provides possi- 
ble interpretations of the effects of the regulatory 
sequences presented above and leads to the in- 
troduction of new parameters of regulation, name- 
ly competition between tRNAs or between tRNA 
and RF, tRNA availability in the cell and 
numerous other metabolic factors and 
physiological conditions that may affect such com- 
petitions. 
The kinetic theory of accuracy elaborated by 
Hopfield [96] and by Ninio [97] has been used by 
these authors to describe among other mechanisms 
the elongation step of protein synthesis in pro- 
karyotes (reviews [98,99]). Its predictions have 
been confirmed in many cases by experimental 
observations (recent reviews [lOO,lOl]). The main 
features of the theory and its consequences can 
apply to termination in both prokaryotes and 
eukaryotes. Although all the experimental support 
mainly comes from prokaryotic systems, we shall 
transpose here the theory to the eukaryotic situa- 
tion, assuming that the mechanisms of elongation 
and termination are, if not identical, at least very 
similar in both systems. 
Let us consider a ribosome translating a given 
codon in an mRNA. In principle, all the 
aminoacyl-tRNAs present in the cell in the form of 
ternary complexes with elongation factor 1 (EFl: 
the counterpart of the prokaryotic EF-Tu factor) 
and GTP are candidates for interacting with the 
codon at the ribosomal A site. The minimal 
mechanism of elongation involves two steps. In the 
first one, called ‘substrate selection’ [loo] or ‘in- 
itial recognition’ [loll, one of the ternary com- 
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plexes binds to the ribosomal A site and either 
dissociates or undergoes GTP hydrolysis. In the 
second step that follows GTP hydrolysis and is 
called ‘proofreading’, the aminoacyl-tRNA either 
is incorporated into the nascent protein chain or 
falls off the ribosome. Peptide bond formation re- 
quires that the EFl-GDP complex has left the 
ribosome [102]. Thus, three situations are en- 
countered at a given codon: (i) ternary complexes 
that weakly interact with the ribosome dissociate 
before GTP hydrolysis; (ii) ternary complexes that 
stick better to the ribosome, pass the GTP hydroly- 
sis screen but may still dissociate from the ribo- 
some faster than does the EFl-GDP complex; (iii) 
finally, ternary complexes that stay on the ribo- 
some long enough for GTP hydrolysis and disso- 
ciation of the EFl-GDP complex to occur, thus 
allowing peptide bond formation. In a highly ac- 
curate system, all non-cognate ternary complexes 
are rejected at either the first or second step and 
only cognate ternary complexes lead to peptide 
bond formation. 
This model of accuracy provides a good basis 
for understanding the parameters of inaccuracy 
and in particular the regulation of the suppression 
of termination codons. Indeed, suppression can be 
regarded as the competition for a nonsense codon 
between the RF and all the ternary complexes 
among which one is acting as a suppressor. It 
follows first that crucial determinants of regula- 
tion of suppression are the availability and relative 
amount of tRNA species, natural suppressor 
tRNAs and RF. Any imbalance in the aminoacyl- 
tRNA population may favour misreading and 
nonsense suppression. This is illustrated in the case 
of MO-MuLV (see section 3.2.1). One may also 
suggest hat the imbalance concerns the concentra- 
tion of RF by some sequestration mechanism oc- 
curring upon viral infection. Similarly, 
compartmentalization of natural suppressor 
tRNAs may control their utilization for specific 
purposes. 
Returning to the minimal model of peptide chain 
elongation, it is also clear that the efficiency of 
suppression is determined by the value and possi- 
ble variations of the ‘sticking time’ [99] of the sup- 
pressor ternary complex to the ribosome relative to 
the average time of GTP hydrolysis and when the 
second step is allowed to proceed relative to the 
average time required for the dissociation of the 
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EFl-GDP complex from the ribosome. Any factor 
increasing the sticking time of a natural suppressor 
tRNA on its ‘non-cognate’ termination codon will 
increase its probability of participating in peptide 
chain elongation. Undermodification of bases at 
the level of the anticodon (see section 3.2.1) as well 
as codon context are examples of such factors. At 
least two hypotheses have been proposed to ex- 
plain the involvement of the bases adjacent to a 
termination codon in increasing suppression effi- 
ciency: the ‘swollen codon’ hypothesis and the 
‘tRNA-tRNA interaction’ hypothesis [80,103]. 
The swollen codon hypothesis suggests a 4 bp or 
even a 5 bp codon-anticodon interaction; however, 
this hypothesis appears rather unlikely when con- 
sidering the conformation of the tRNA loop at the 
ribosomal A site [ 1041. The second hypothesis sug- 
gests that tRNA-tRNA interaction can occur be- 
tween the peptidyl-tRNA at the P site and the 
acylated suppressor tRNA at the A site. If 
favourable, this interaction would counterbalance 
the weak non-cognate interaction of the natural 
suppressor tRNA with the termination codon, 
thereby increasing the sticking time of this tRNA 
and allowing peptide bond formation. In this 
respect, the tertiary structure of the suppressor 
tRNA and its pattern of base modifications, 
especially outside of the anticodon, play a decisive 
role. 
One of the most interesting predictions of the 
kinetic theory is that factors which affect the rate 
of GTP hydrolysis or of dissociation of the 
EFl-GDP complex from the ribosome in a non- 
specific manner (i.e. independently of the nature 
of the ternary complex bound to the ribosome) 
may have a specific effect on the probability of a 
given ternary complex participating in peptide 
chain elongation. Indeed, for a given system and in 
a given environment, the average time of GTP 
hydrolysis and of EFl-GDP complex dissociation 
from the ribosome is very likely constant [loll. 
Physiological or metabolic variations in the cell 
may affect these constants. Consequently, the 
ratios of the sticking times of all ternary complexes 
to these modified constants are changed. For some 
ternary complexes this may transform the interac- 
tion with the ribosome [99,101]. For example, let 
us imagine a metabolic variation leading to more 
rapid GTP hydrolysis on the ribosome (modifica- 
tion of a GTPase activity, variations in the GTP or 
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GDP concentrations.. .). The average time of GTP 
hydrolysis is thus shortened and becomes closer to 
the sticking time of some weakly interacting ter- 
nary complexes. Such complexes that would have 
otherwise been rejected can now pass the ‘initial 
recognition’ step. Similarly, changes that ac- 
celerate the dissociation of the EFl-GDP complex 
from the ribosome (mutation or alteration in EFl 
or in the ribosome.. .) will increase the probability 
of incorporating non-cognate amino acids into the 
peptide chain. Thus, both GTP metabolism and 
EFl recycling appear to play a key role in accuracy 
and therefore in suppression [98-101,105,106]. 
presence of mouse liver tRNAs. Rules for codon- 
anticodon interactions are upset in nonsense sup- 
pression where unorthodox G : G or A : A pairings 
are involved. The translated reading frame is no 
longer reliably determined by the initiation codon, 
since frameshifts may occur to skip undesirable 
termination codons and synthesize complete 
translation products. 
A great variety of other factors have been 
described that influence the efficiency of suppres- 
sion. High Mg2+ concentrations as well as 
polyamines stimulate the suppression of UAG and 
of UGA codons [18,107,108]. Readthrough is also 
more efficient at low than at high temperatures 
[109]. However, these effects are more difficult to 
interpret precisely, since ions and temperature like- 
ly affect both non-specific kinetic parameters 
(GTP hydrolysis and dissociation of the EFl-GDP 
complex) and the respective sticking times of each 
ternary complex and RF entering the competition. 
Not only suppression of termination codons but 
also frameshift can be explained by the kinetic 
theory. Recently, a kinetic model of ribosome 
translocation has been proposed [l lo] and the in- 
creasing number of natural frameshifts observed in 
eukaryotic mRNAs should provide a good ex- 
perimental basis for developing this model. 
The translational regulations of gene expression 
discussed in this paper take advantage of and 
amplify defects or rather properties inherent to the 
translation process and apparatus. Indeed, since 
the early genetic studies on prokaryotic transla- 
tion, it has become apparent that protein biosyn- 
thesis is the outcome of elementary processes of 
low fidelity and that evolution has developed 
numerous devices for achieving high accuracy in 
gene expression [ 1111. Hence, frameshifting and 
nonsense suppression were first observed in the 
selection of phenotypic reversion of frameshift and 
nonsense mutations and they presumably occur at 
low levels in all cellular translations. Of course if 
these inherent ‘errors’ of translation were above 
background level, accuracy of translation would 
be definitely at stake in any living organism. It 
seems rather that evolution has optimized the effi- 
ciency of these ‘errors’ at specific sites, turning 
them into biologically significant sites of 
regulation. 
5. CONCLUSION 
The study of termination leads to the shattering 
of some of the early, established rules of protein 
biosynthesis. The universality of the genetic code is 
denied by the finding that nonsense codons in one 
organism are sense codons in another organism. A 
nonsense codon can no longer be defined as a 
codon not recognized by any tRNA, since natural- 
ly occurring tRNAs exist that possess an anticodon 
complementary to a termination codon. The 
dogma of the non-ambiguity of the genetic code is 
also broken: a codon may have two or more mean- 
ings. The UAG codon of TMV, for instance, 
means either termination, Tyr when translated in 
the presence of tobacco tRNAs, Leu in the 
presence of calf liver tRNAs, or Gln in the 
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